Mammalian target of rapamycin (mTOR) Inhibitors.

This publication has 17 references indexed in Scilit:

• Targeting mTOR signaling for cancer therapy
  Current Opinion in Pharmacology, 2003
• Phospholipase D confers rapamycin resistance in human breast cancer cells
  Oncogene, 2003
• Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin
  Molecular and Cellular Biology, 2002
• Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
  Proceedings of the National Academy of Sciences, 2001
• The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
  Oncogene, 2000
• Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
  Proceedings of the National Academy of Sciences, 1996
• Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells
  Published by Springer Nature ,1995
• Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.
  The Journal of Antibiotics, 1978
• Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
  The Journal of Antibiotics, 1975
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975